MiR-1268b confers chemosensitivity in breast cancer by targeting ERBB2-mediated PI3K-AKT pathway

Chemoresistance represents a major obstacle to effective therapy for breast cancer. Emerging evidences associated aberrantly expressed miRNAs with tumor development and chemoresistance. MiR-1268b has never been studied in any cancers before, and its roles in mediating tumor progression and drug resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wen-Jie, Chen, Xu, Wang, Ya-Wen, Liu, Hai-Ting, Ma, Ran-Ran, Gao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685697/
https://www.ncbi.nlm.nih.gov/pubmed/29163776
http://dx.doi.org/10.18632/oncotarget.20099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685697/
https://www.ncbi.nlm.nih.gov/pubmed/29163776
http://dx.doi.org/10.18632/oncotarget.20099

Ejemplares similares